Para
Your blood strengthening assistant
In 2100, the elite adopted a 48-hour work schedule and promoted artificial organ tissue technology, resulting in longer and more intense work in various positions. The high population density contributed to the spread of epidemics and a series of blood-related fatalities, with many people dying due to a lack of healthy modified blood. To address the shortage of modified blood and ensure basic blood safety for the public, the government and the elite launched the "Para" project in collaboration with biogenetic companies. They conducted extensive experimental research and found that plant proteins could be modified to resemble human blood sources, solving the shortage of modified blood. During their synthesis experiments, scientists discovered that the blood of certain plants, such as Lohan pine, crystal orchid, and bristlecone orchid, could strengthen the heart and lungs, prevent tumor diseases, and increase lifespan. However, these plants were also rare and susceptible to death.
The elite, who could use these special blood plants to treat their own blood diseases and improve their physical capacity to work more efficiently for 48 hours, also saw them as a way to increase their wealth. As a result, the "Para" project began offering customized plant blood products to the general public, combining the process of purchasing, transporting, and injecting them with medical resources to provide safe and reliable injections for users with different conditions. "Para" offers a specialized service for enhancing the human body through blood modification.
Covid-19 pandemic still spreading drives advancement in research on healthy blood technologies
3D-printed organs
Protein oral vaccines are produced by a plant molecular farm.
Can people become immortal?
Can immortality be a part of the resource?
How will the right to eternal life be governed?
To make the future more convincing, I conceived the future plant image, the blood product style, the blood bag packaging and the plant blood custom application around the plant blood product, here are the four parts related to the plant blood product.
Selection of structures similar to the human haemoglobin gene in transgenic tobacco root cells combined with functional cellular structures of Monotropa uniflora Linn.
I designed the blood plant structure by combining plant cell structures of different blood types and tobacco cell structures, and visually merging the original plant form.
Selection of structures similar to the human haemoglobin gene in transgenic tobacco root cells combined with functional cellular structures of Monotropa uniflora Linn.
Selection of structures similar to the human haemoglobin gene in transgenic tobacco root cells combined with functional cellular structures of Monotropa uniflora Linn.
Selection of structures similar to the human haemoglobin gene in transgenic tobacco root cells combined with functional cellular structures of Monotropa uniflora Linn.
In the production of the product, I used protein crystallization technology to transport, store, and sell the main component of blood, hemoglobin protein, in a stable crystal structure. Users can obtain injectable blood by adding common components of plasma and plasma. The protein crystal form combines the base with the protein crystal block, and also adds an imaging tag to provide customized products for each customized customer.
Para's name is taken from our first product, the Monotropa uniflora Linn. It is a saprophytic plant that lives on decaying plants and is symbiotic. In my product, people use blood from rare plants for survival and self-enhancement, which is also a symbiotic state.
To make our products accessible to the general public, we offer a convenient and customizable full-service product for customers with different blood function needs, including a shopping function, logistics tracking function, and sharing function.
